Global searching is not enabled.
Skip to main content
Book

Management of Steroid Sensitive Nephrotic Syndrome

Completion requirements
"last update: 9 September 2026"                                                                                Download Guideline

- References

1.     Neeraja Yelugam and Supraja Jannu (2019) (Nov 12th). Causes and

Pathophysiology of Nephrotic Syndrome in Childhood, Renal Diseases,

Edward T. Zawada Jr. and Sohail Abdul Salim,-IntechOpen. https://

doi.org/10.5772/intechopen.86825. Available from: https://www.intec

hopen.com/books/renal-diseases/causes-and-pathophysiology-of-

nephrotic-syndrome-in-childhood.

2. McKinney PA, Feltbower RG, Brocklebank JT, Fitzpatrick MM (2001) Time

trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire,

UK. Pediatr Nephrol 16:1040–1044

3. Tallus K, Webb H (2018) Bagga A Management of Steroid Resistant

Nephrotic children and adolescents Lancet. Child AdoleSC Health

2:880–890

4. Moustafa B, Tolba O (2016) Immunosuppressive therapy in children with

steroid resistant, frequently relapsing, and steroid dependent idiopathic

nephrotic syndrome: a single center experience. Electron Physician

8(2):2039–2047

5. Trautmann A, Vivarelli M, Samuel S et al (2020) IPNA clinical practice

recommendations for the diagnosis and management of children with

steroid-resistant nephrotic syndrome. Pediatr Nephrol 35:1529–15614

6. KDIGO 2021 d-kidney disease (2021) Improving Global Outcomes

(KDIGO) Glomerular Disease Work Group. KDIGO 2021 Clinical Practice

Guideline for the management of Glomerular Diseases. Kidney Int

100(45):51-S276 (https://kidigo.org/guidelines/gd/(acessed29/09/2021)

(KDIGO2021))

7. Sadowski CE, Lovric S, Ashraf S, Pabst WL, Gee HY, Kohl S, Engelmann S,

Vega-Warner V, Fang H, Halbritter J, Somers MJ, Tan W, Shril S, Fessi I, Lifton

RP, Bockenhauer D, El-Desoky S, Kari JA, Zenker M, Kemper MJ, Mueller D,

Fathy HM, Soliman NA, SRNS Study Group, Hildebrandt F (2015) A singlegene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J

Am Soc Nephrol 26(6):1279–89

8. Lovric S, Ashraf S, Tan W, Hildebrandt F (2016) Genetic testing in steroidresistant nephrotic.syndrome: when and how? Nephrol Dial Transplant

31(11):1802–1813. https://doi.org/10.1093/ndt/gfv355

9. Warejko JK, Tan W, Daga A, Schapiro D, Lawson JA, Shril S, Lovric S et al

(2018) Whole Exome Sequencing of Patients with Steroid-Resistant

Nephrotic Syndrome. Clin J Am Soc Nephrol 13(1):53–62

10. Lipska-Ziętkiewicz BS (2021) Genetic Steroid-Resistant Nephrotic

Syndrome Overview. In: Adam MP, Ardinger HH, Pagon RA (eds) Gene

Reviews ®. University of Washington, Seattle, Seattle (1993–2021)

11. Mendonca AC, Oliveira EA, Froes BP et al (2015) A predictive model of

progressive chronic kidney disease in idiopathic nephrotic syndrome.

Pediatr Nephrol 30:2011–2020

12.  Abdel Baky A, Omar TEI, Amer YS; Egyptian Pediatric Clinical Practice Guidelines Committee (EPG). Adapting global evidence-based practice guidelines to the Egyptian healthcare context: the Egyptian Pediatric Clinical Practice Guidelines Committee (EPG) initiative. Bull Natl Res Cent. 2023;47(1):88. https://doi.org/10.1186%2Fs42269-023-01059-0

13.  Alshehri A, Almazrou S, Amer Y. Methodological frameworks for adapting global practice guidelines to national context in the Eastern Mediterranean Region. Eastern Mediterranean Health Journal. 2023 Jul 1;29(7). https://www.emro.who.int/emhj-volume-29-2023/volume-29-issue-7/methodological-frameworks-for-adapting-global-practice-guidelines-to-national-context-in-the-eastern-mediterranean-region.html

14.  Schünemann H, Brozek J, Guyatt G, Oxman A (editors). GRADE handbook: handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group; 2013 (Online updated version: https://gdt.gradepro.org/app/handbook/handbook.html Accessed 16/8/2024)

15.  Klugar M, Lotfi T, Darzi AJ, et al. GRADE Guidance 39: Using GRADE-ADOLOPMENT to adopt, adapt or create contextualized recommendations from source guidelines and evidence syntheses. Journal of Clinical Epidemiology. 2024 Aug 6:111494. https://doi.org/10.1016/j.jclinepi.2024.111494 (in press)

16.  Amer YS, Elzalabany MM, Omar TI, Ibrahim AG, Dowidar NL. The ‘Adapted ADAPTE’: an approach to improve utilization of the ADAPTE guideline adaptation resource toolkit in the A lexandria C enter for E vidence‐B ased C linical P ractice G uidelines. Journal of evaluation in clinical practice. 2015 Dec;21(6):1095-106. https://doi.org/10.1111/jep.12479

17.  Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L; AGREE Next Steps Consortium. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010 Dec 14;182(18):E839-42. https://doi.org/10.1503%2Fcmaj.090449  

18.   Agree II (2022) AGREE Enterprise website. Available at: https://www.agreetrust.org/resource-centre/agree-ii/  (Accessed: 16/8/2024).

19.  Song Y, Alonso-Coello P, Ballesteros M, et al. A Reporting Tool for Adapted Guidelines in Health Care: The RIGHT-Ad@pt Checklist[J]. Annals of Internal Medicine, 2022, 175(5):710-719. https://doi.org/10.7326/M21-4352  (Official RIGHT Statement Website: http://www.right-statement.org/extensions/13 Accessed 16/8/2024)